Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 7, 2025Infectious Microbes & DiseasesOpen Access

Comparison of Clinical and Laboratory Features Between COVID-19 and Community-Acquired Pneumonia in Children

View Full Paper
Ask AI
Bookmark
Share

Authors

HLHaiyan LvTTTianbin TangFZFangfang Zhou

Discussion

Loading...

Member takes

Overview

Retrospective cohort study shows distinct features in children with COVID-19 vs CAP, suggesting tailored treatment is needed.

Key Points

  • COVID-19 patients exhibited higher fever and lower cough incidence compared to other CAP patients.
  • Antibiotic use was less frequent in the COVID-19 group, indicating different treatment needs.
  • Children with COVID-19 CAP had lower white blood cell and lymphocyte counts, highlighting immune response differences.
  • Significant differences in nutritional and renal function metrics were observed, which may guide clinical evaluation.

Cite This Study

Lv et al. (2025) studied this question.

synapsesocial.com/papers/689dfe88d61984b91e13b94dhttps://doi.org/10.1097/im9.0000000000000188
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Clinical epidemiology of community-acquired pneumonia in children before, during, and after the COVID-19 pandemic, and independent risk factors analysis for severe community-acquired pneumonia2025 · 7 citations
  2. 2Etiological Structure of Community-Acquired Pneumonia in the period of COVID-19 epidemic2024 · 1 citations
  3. 3Analysis of Childhood Pneumonia: A Comparison Between the Pre- and During the COVID-19 Pandemic in a Reference Hospital in Brazil2024
  4. 4Changes in the pathogenic characteristics of hospitalized children with community-acquired pneumonia in Changzhou, China, 2018–20232026
  5. 5Analysis of Pathogen Detection Data in 898 Pediatric Patients Hospitalized with Community-Acquired Pneumonia2024